The role of initial neck dissection for patients with node-positive oropharyngeal squamous cell carcinomas
The role of initial neck dissection for patients with node-positive oropharyngeal squamous cell carcinomas
复制标题
初次颈清扫术对淋巴结阳性口咽鳞状细胞癌患者的作用
DOI:
10.1016/j.oraloncology.2014.03.003
复制
发表时间:
2014
期刊:
影响因子:
4.8
通讯作者:
M. Fuji
中科院分区:
文献类型:
--
作者:
T. Sakashita;A. Homma;R. Hayashi;K. Kawabata;K. Yoshino;S. Iwae;Y. Hasegawa;K. Nibu;T. Kato;K. Shiga;K. Matsuura;N. Monden;M. Fuji
BackgroundThe current study sought to assess the role of initial neck dissection (ND) for patients with node-positive oropharyngeal squamous cell carcinomas (OPSCC).MethodsThe data for 202 patients with previously untreated node-positive OPSCC were gathered from 12 institutions belonging to the Head and Neck Cancer Study Group in the Japan Clinical Oncology Group. These patients were categorized into two groups, consisting of the initial ND group and the wait-and-see group, according to treatment policy.ResultsRegional recurrence was observed in 17 of 93 patients undergoing initial ND, whereas, recurrent or persistent diseases were observed in 40 of 109 patients who did not undergo initial ND. The 4-year overall survival rates (OS) for the wait-and-see group and initial ND groups were 74.0% and 78.7%, respectively, and the 4-year regional control rates (RC) for each group were 77.6% and 84.9%. There were no significant differences in either OS or RC (p= 0.3440 andp= 0.2382, respectively). However, for patients with N3 disease, the 4-year OS of the initial ND group (100%) was favorable. For patients with N2a disease, the 4-year RC of the initial ND group was higher than that of the wait-and-see group statistically (100% vs 62.5%,p= 0.0156).ConclusionsThe role of initial ND was limited in patients with node-positive OPSCC. The treatment strategy not involving initial ND is considered feasible and acceptable when nodal evaluation after definitive radiotherapy or chemoradiotherapy is applied adequately. However, it is possible that initial ND improves outcomes in patients with resectable large-volume nodal disease.